Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07478887Not ApplicableRecruiting

Impact of the Corrie Lipids Digital Health Program on Lipid Optimization

NCT06471036Not ApplicableRecruiting

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

NCT04749784Not ApplicableUnknown

Effects of Arterin Cholesterol for Reduction of Lipid Levels

Showing all 3 trials

Research Network

Activity Timeline